Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1989 1
1992 1
1994 2
1995 4
1996 5
1997 6
1998 3
1999 6
2000 4
2001 2
2002 4
2003 2
2004 4
2005 6
2006 9
2007 12
2008 6
2009 9
2010 12
2011 24
2012 22
2013 20
2014 26
2015 27
2016 31
2017 42
2018 59
2019 60
2020 69
2021 44
Text availability
Article attribute
Article type
Publication date

Search Results

462 results
Results by year
Filters applied: . Clear all
Page 1
The interplay between depression and tuberculosis.
Zhang K, Wang X, Tu J, Rong H, Werz O, Chen X. Zhang K, et al. Among authors: rong h. J Leukoc Biol. 2019 Sep;106(3):749-757. doi: 10.1002/JLB.MR0119-023R. Epub 2019 Jun 28. J Leukoc Biol. 2019. PMID: 31254317 Review.
Meta-Analysis of Prognosis of Different Treatments for Symptomatic Moyamoya Disease.
Li Q, Gao Y, Xin W, Zhou Z, Rong H, Qin Y, Li K, Zhou Y, Wang J, Xiong J, Dong X, Yang M, Liu Y, Shen J, Wang G, Song A, Zhang J. Li Q, et al. Among authors: rong h. World Neurosurg. 2019 Jul;127:354-361. doi: 10.1016/j.wneu.2019.04.062. Epub 2019 Apr 14. World Neurosurg. 2019. PMID: 30995556 Review.
Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective.
Shebley M, Sandhu P, Emami Riedmaier A, Jamei M, Narayanan R, Patel A, Peters SA, Reddy VP, Zheng M, de Zwart L, Beneton M, Bouzom F, Chen J, Chen Y, Cleary Y, Collins C, Dickinson GL, Djebli N, Einolf HJ, Gardner I, Huth F, Kazmi F, Khalil F, Lin J, Odinecs A, Patel C, Rong H, Schuck E, Sharma P, Wu SP, Xu Y, Yamazaki S, Yoshida K, Rowland M. Shebley M, et al. Among authors: rong h. Clin Pharmacol Ther. 2018 Jul;104(1):88-110. doi: 10.1002/cpt.1013. Epub 2018 Feb 2. Clin Pharmacol Ther. 2018. PMID: 29315504 Free PMC article. Review.
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.
Wilhelm SM, Carter C, Tang L, Wilkie D, McNabola A, Rong H, Chen C, Zhang X, Vincent P, McHugh M, Cao Y, Shujath J, Gawlak S, Eveleigh D, Rowley B, Liu L, Adnane L, Lynch M, Auclair D, Taylor I, Gedrich R, Voznesensky A, Riedl B, Post LE, Bollag G, Trail PA. Wilhelm SM, et al. Among authors: rong h. Cancer Res. 2004 Oct 1;64(19):7099-109. doi: 10.1158/0008-5472.CAN-04-1443. Cancer Res. 2004. PMID: 15466206 Free article.
462 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page